{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:04:47Z","timestamp":1777950287887,"version":"3.51.4"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.biopha.2016.05.035","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T08:35:24Z","timestamp":1465979724000},"page":"713-721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test"],"prefix":"10.1016","volume":"82","author":[{"given":"Sattar","family":"Ostadhadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Ahangari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Nikoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Norouzi-Javidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Zolfaghari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farahnaz","family":"Jazaeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Chamanara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyhaneh","family":"Akbarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad-Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.05.035_bib0005","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4088\/JCP.v63n0813","article-title":"Lamotrigine as an augmentation agent in treatment-resistant depression","volume":"63","author":"Barbee","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2016.05.035_bib0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4088\/JCP.v64n0407","article-title":"A double-blind randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes","volume":"64","author":"Barbosa","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2016.05.035_bib0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0278-5846(03)00037-X","article-title":"The influence of anticonvulsant and antioxidant drugs on nitric oxide level and lipid peroxidation in the rat brain during penthylenetetrazole-induced epileptiform model seizures","volume":"27","author":"Bashkatova","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2016.05.035_bib0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00127893-200203000-00002","article-title":"New antiepileptic drugs","volume":"8","author":"Bazil","year":"2002","journal-title":"The neurologist"},{"key":"10.1016\/j.biopha.2016.05.035_bib0025","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2016.05.035_bib0030","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.neuint.2004.03.015","article-title":"Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages","volume":"45","author":"Bender","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2016.05.035_bib0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2016.05.035_bib0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1139\/jpn.0537","article-title":"Evidence for the activity of lamotrigine at 5-HT^ sub 1A^ receptors in the mouse forced swimming test","volume":"30","author":"Bourin","year":"2005","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.biopha.2016.05.035_bib0045","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.neubiorev.2007.03.001","article-title":"The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders","volume":"31","author":"Bourin","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2016.05.035_bib0050","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/S0924-977X(99)00024-3","article-title":"Lamotrigine in the treatment of bipolar depression","volume":"9","author":"Bowden","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02761776","article-title":"Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain","volume":"10","author":"Boyer","year":"1998","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2016.05.035_bib0060","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/S0924-977X(99)00023-1","article-title":"Controlled trials in bipolar I depression: focus on switch rates and efficacy","volume":"9","author":"Calabrese","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0065","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression","volume":"60","author":"Calabrese","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2016.05.035_bib0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0165-0327(98)00161-X","article-title":"Current research on rapid cycling bipolar disorder and its treatment","volume":"67","author":"Calabrese","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.biopha.2016.05.035_bib0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.euroneuro.2006.01.003","article-title":"Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test","volume":"16","author":"Consoni","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0080","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0165-0173(00)00018-7","article-title":"Roles of NMDA receptor activity and nitric oxide production in brain development","volume":"32","author":"Contestabile","year":"2000","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.biopha.2016.05.035_bib0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2016.05.035_bib0090","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0028-3908(00)00051-4","article-title":"The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro","volume":"39","author":"Cunningham","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2016.05.035_bib0095","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1097\/00001756-200011270-00022","article-title":"Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice","volume":"11","author":"da Silva","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2016.05.035_bib0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-002-1335-4","article-title":"Antidepressant-like effects in various mice strains in the forced swimming test","volume":"166","author":"David","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopha.2016.05.035_bib0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0005-2728(99)00024-9","article-title":"Guanylate cyclase and the\u22c5 NO\/cGMP signaling pathway","volume":"1411","author":"Denninger","year":"1999","journal-title":"Biochim. Biophys. Acta (BBA)-Bioenerg."},{"key":"10.1016\/j.biopha.2016.05.035_bib0110","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.pnpbp.2007.02.008","article-title":"Involvement of l-arginine\u2013nitric oxide\u2013cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice","volume":"31","author":"Dhir","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2016.05.035_bib0115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/phrs.1997.0245","article-title":"Anxiolytic and antidepressant properties of methylene blue in animal models","volume":"36","author":"Eroglu","year":"1997","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2016.05.035_bib0120","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","article-title":"NO as a signalling molecule in the nervous system","volume":"135","author":"Esplugues","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0125","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00004714-200012000-00004","article-title":"A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders","volume":"20","author":"Frye","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2016.05.035_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hrp\/8.1.1","article-title":"Novel anticonvulsants: a new generation of mood stabilizers?","volume":"8","author":"Ghaemi","year":"2000","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.biopha.2016.05.035_bib0140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00213-009-1609-1","article-title":"NMDA receptor\/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test","volume":"206","author":"Ghasemi","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.biopha.2016.05.035_bib0145","first-page":"584","article-title":"NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test","volume":"24","author":"Ghasemi","year":"2009","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.biopha.2016.05.035_bib0150","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.euroneuro.2007.07.011","article-title":"Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test","volume":"18","author":"Ghasemi","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1399-5618.2003.00067.x","article-title":"Antidepressant-induced mania: an overview of current controversies","volume":"5","author":"Goldberg","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.biopha.2016.05.035_bib0160","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.neubiorev.2007.05.007","article-title":"Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement","volume":"31","author":"Gould","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2016.05.035_bib0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2016.03.034","article-title":"Involvement of nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tropisetron and ondansetron in mice forced swimming test and tail suspension test","volume":"78","author":"Haj-Mirzaian","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0170","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1007\/s00213-015-4004-0","article-title":"Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests","volume":"232","author":"Haj-Mirzaian","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.biopha.2016.05.035_bib0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1139\/cjpp-2015-0429","article-title":"Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl D-aspartate and opioid receptors","volume":"94","author":"Haj-Mirzaian","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2014.03.053","article-title":"Opioid\/NMDA receptors blockade reverses the depressant-like behavior of foot shock stress in the mouse forced swimming test","volume":"735","author":"Haj-Mirzaian","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0185","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0028-3908(03)00030-3","article-title":"Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors","volume":"44","author":"Harkin","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2016.05.035_bib0190","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.euroneuro.2003.08.010","article-title":"Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test","volume":"14","author":"Harkin","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(99)00191-0","article-title":"Nitric oxide synthase inhibitors have antidepressant-like properties in mice: 1. Acute treatments are active in the forced swim test","volume":"372","author":"Harkin","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0200","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0278-5846(91)90011-O","article-title":"Behavioral models in mice. Implication of the alpha noradrenergic system","volume":"15","author":"Hasco\u00ebt","year":"1991","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2016.05.035_bib0205","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2016.05.035_bib0210","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0166-4328(02)00084-0","article-title":"Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats","volume":"134","author":"Heiberg","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2016.05.035_bib0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00213-006-0326-2","article-title":"Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects","volume":"185","author":"Joca","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.biopha.2016.05.035_bib0220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2007.03.003","article-title":"Antidepressant-like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system","volume":"565","author":"Kaster","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0225","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S1461145705005316","article-title":"Involvement of nitric oxide\u2013cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test","volume":"8","author":"Kaster","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0230","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.jcp.0000088915.02635.e8","article-title":"Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders","volume":"23","author":"Ketter","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0235","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2015.12.006","article-title":"The involvement of NMDA receptor\/NO\/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test","volume":"612","author":"Khan","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2016.05.035_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2015.11.009","article-title":"Involvement of N-methyl-d-aspartate receptors in the antidepressant-like effect of 5-hydroxytryptamine 3 antagonists in mouse forced swimming test and tail suspension test","volume":"141","author":"Kordjazy","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2016.05.035_bib0245","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejphar.2015.06.030","article-title":"Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice","volume":"762","author":"Kordjazy","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0250","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1528-1157.2001.04501.x","article-title":"Effectiveness of first antiepileptic drug","volume":"42","author":"Kwan","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2016.05.035_bib0255","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1097\/00001756-200109170-00043","article-title":"Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses","volume":"12","author":"Law","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2016.05.035_bib0260","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1046\/j.1471-4159.1995.64020636.x","article-title":"Inhibition by lamotrigine of the generation of nitric oxide in rat forebrain slices","volume":"64","author":"Lizasoain","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2016.05.035_bib0265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-2999(95)00851-9","article-title":"Inhibition of morphine withdrawal by lamotrigine: involvement of nitric oxide","volume":"299","author":"Lizasoain","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0270","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1471-4159.2006.03988.x","article-title":"Nitric oxide, cell bioenergetics and neurodegeneration","volume":"97","author":"Moncada","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2016.05.035_bib0275","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jpsychires.2011.11.009","article-title":"Ascorbic acid treatment similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress","volume":"46","author":"Moretti","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.biopha.2016.05.035_bib0280","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4088\/JCP.v63n0411","article-title":"Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study","volume":"63","author":"Normann","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2016.05.035_bib0285","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(95)00057-W","article-title":"Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims","volume":"675","author":"Nowak","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2016.05.035_bib0290","article-title":"Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice","author":"Ostadhadi","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0295","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2016.03.004","article-title":"Involvement of NMDA receptors and l-arginine\/nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test","volume":"122","author":"Ostadhadi","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2016.05.035_bib0300","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biopha.2016.04.026","article-title":"Antidepressant effect of pramipexole in mice forced swimming test: a cross talk between dopamine receptor and NMDA\/nitric oxide\/cGMP pathway","volume":"81","author":"Ostadhadi","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2016.05.035_bib0305","first-page":"1","article-title":"Involvement of NO\/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test","author":"Ostadhadi","year":"2016","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0310","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-3565(25)38715-X","article-title":"Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments","volume":"269","author":"Paul","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2016.05.035_bib0315","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1300.016","article-title":"Glutamate and depression","volume":"1003","author":"Paul","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2016.05.035_bib0320","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.biopha.2016.05.035_bib0325","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharm. Th\u00e9r."},{"key":"10.1016\/j.biopha.2016.05.035_bib0330","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1017\/S1461145711001003","article-title":"Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder","volume":"15","author":"Ramadan","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0335","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004850-200303000-00006","article-title":"Lamotrigine augmentation in unipolar depression","volume":"18","author":"Rocha","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0340","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rog\u00f3\u017c","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2016.05.035_bib0345","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2011.06.011","article-title":"Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway","volume":"224","author":"Sadaghiani","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2016.05.035_bib0350","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2016.05.035_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-8-47","article-title":"Modulatory effects of nitric oxide-active drugs on the anticonvulsant activity of lamotrigine in an experimental model of partial complex epilepsy in the rat","volume":"8","author":"Sardo","year":"2007","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.biopha.2016.05.035_bib0360","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0365","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(98)00580-9","article-title":"Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats","volume":"358","author":"Southam","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.05.035_bib0370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0165-0327(00)00164-6","article-title":"Elevated plasma nitrate levels in depressive states","volume":"63","author":"Suzuki","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.biopha.2016.05.035_bib0375","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.0953-816X.2004.03327.x","article-title":"Species differences in the localization of cGMP-producing and NO-responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry","volume":"19","author":"Van Staveren","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.biopha.2016.05.035_bib0380","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(02)00312-1","article-title":"Antidepressant-and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice","volume":"140","author":"Volke","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2016.05.035_bib0385","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216305601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216305601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:56:51Z","timestamp":1777877811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216305601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":77,"alternative-id":["S0753332216305601"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.05.035","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}